2315

HKSE:2315

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

  • Stock

HKD

Last Close

6.37

30/08 07:58

Market Cap

3.05B

Beta: -

Volume Today

153K

Avg: 161.05K

PE Ratio

−7.72

PFCF: −5.73

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
revenue
65.53M
-
65.53M
0%
111.75M
70.54%
111.75M
0%
114.57M
2.52%
114.57M
0%
152.38M
33.00%
152.38M
0%
163.42M
7.25%
163.42M
0%
195.04M
19.35%
195.04M
0%
cost of revenue
27.91M
-
27.91M
0%
20.74M
25.67%
20.74M
0%
25.96M
25.17%
25.96M
0%
43.14M
66.15%
43.14M
0%
45.27M
4.93%
45.27M
0%
57.73M
27.55%
57.73M
0%
gross profit
37.62M
-
37.62M
0%
91.01M
141.91%
91.01M
0%
88.60M
2.64%
88.60M
0%
109.23M
23.29%
109.23M
0%
118.15M
8.16%
118.15M
0%
137.30M
16.21%
137.30M
0%
selling and marketing expenses
9.30M
-
9.30M
0%
11.72M
25.98%
11.72M
0%
12.12M
3.45%
12.12M
0%
13.00M
7.29%
13.00M
0%
14.75M
13.45%
14.75M
0%
16.66M
12.93%
16.66M
0%
general and administrative expenses
45.59M
-
45.59M
0%
48.47M
6.34%
48.47M
0%
53.81M
11.01%
53.81M
0%
77.89M
44.75%
77.89M
0%
58.77M
24.56%
58.77M
0%
84.36M
43.56%
84.36M
0%
selling general and administrative expenses
54.89M
-
54.89M
0%
60.19M
9.67%
60.19M
0%
65.93M
9.54%
65.93M
0%
90.90M
37.86%
90.90M
0%
73.52M
19.12%
73.52M
0%
101.02M
37.41%
101.02M
0%
research and development expenses
105.46M
-
105.46M
0%
173.78M
64.79%
173.78M
0%
163.91M
5.68%
163.91M
0%
185.67M
13.28%
185.67M
0%
123.98M
33.22%
123.98M
0%
113.20M
8.70%
113.20M
0%
other expenses
cost and expenses
184.00M
-
184.00M
0%
252.64M
37.31%
252.64M
0%
241.77M
4.30%
241.77M
0%
298.86M
23.62%
298.86M
0%
237.53M
20.52%
237.53M
0%
266.16M
12.05%
266.16M
0%
operating expenses
156.09M
-
156.09M
0%
231.90M
48.57%
231.90M
0%
215.80M
6.94%
215.80M
0%
255.72M
18.50%
255.72M
0%
192.27M
24.81%
192.27M
0%
208.42M
8.40%
208.42M
0%
interest expense
41.66M
-
52.77M
-
ebitda
-97.20M
-
-97.20M
0%
-110.53M
13.71%
-110.53M
0%
-101.84M
7.86%
-101.84M
0%
-126.56M
24.27%
-126.56M
0%
-36.09M
71.48%
-36.09M
0%
-14.67M
59.36%
-14.67M
0%
operating income
-119.93M
-
-119.93M
0%
-139.60M
16.40%
-139.60M
0%
-140.54M
0.67%
-140.54M
0%
-161.76M
15.09%
-161.76M
0%
-78.12M
51.70%
-78.12M
0%
-67.63M
13.44%
-67.63M
0%
depreciation and amortization
22.73M
-
22.73M
0%
29.07M
27.92%
29.07M
0%
38.70M
33.12%
38.70M
0%
35.20M
9.06%
35.20M
0%
42.03M
19.42%
42.03M
0%
52.96M
26.00%
52.96M
0%
total other income expenses net
-4.71M
-
-4.71M
0%
-8.58M
82.32%
-8.58M
0%
4.25M
149.48%
4.25M
0%
-2.62M
161.78%
-2.62M
0%
-16.57M
531.76%
-16.57M
0%
-27.76M
67.50%
-27.76M
0%
income before tax
-124.64M
-
-124.64M
0%
-148.18M
18.89%
-148.18M
0%
-136.30M
8.02%
-136.30M
0%
-164.38M
20.60%
-164.38M
0%
-94.69M
42.39%
-94.69M
0%
-95.38M
0.73%
-95.38M
0%
income tax expense
-1K
-
-1K
0%
-32.50K
3,150%
-32.50K
0%
-104K
220.00%
-104K
0%
402K
486.54%
402K
0%
210K
47.76%
210K
0%
1.19M
465.71%
1.19M
0%
net income
-124.64M
-
-124.64M
0%
-148.15M
18.87%
-148.15M
0%
-136.19M
8.07%
-136.19M
0%
-164.78M
20.99%
-164.78M
0%
-94.90M
42.41%
-94.90M
0%
-96.57M
1.76%
-96.57M
0%
weighted average shs out
360.40M
-
360.40M
0%
364.43M
1.12%
364.43M
0%
374.93M
2.88%
374.93M
0%
387.08M
3.24%
387.08M
0%
398.38M
2.92%
398.38M
0%
398.25M
0.03%
398.25M
0%
weighted average shs out dil
360.40M
-
360.40M
0%
364.43M
1.12%
364.43M
0%
374.93M
2.88%
374.93M
0%
387.08M
3.24%
387.08M
0%
398.38M
2.92%
398.38M
0%
398.25M
0.03%
398.25M
0%
eps
-0.35
-
-0.35
0%
-0.41
17.14%
-0.41
0%
-0.36
12.20%
-0.36
0%
-0.43
19.44%
-0.43
0%
-0.24
44.19%
-0.24
0%
-0.24
0%
-0.24
0%
epsdiluted
-0.35
-
-0.35
0%
-0.41
17.14%
-0.41
0%
-0.36
12.20%
-0.36
0%
-0.43
19.44%
-0.43
0%
-0.24
44.19%
-0.24
0%
-0.24
0%
-0.24
0%

All numbers in HKD (except ratios and percentages)